---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-047561"
form_type: "8-K"
ticker: "SSII"
cik: "0001676163"
company_name: "SS Innovations International, Inc."
filed_at: "2025-05-27T23:59:59+00:00"
generated_at: "2026-05-20T10:51:58.851700+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# SSi Mantra robot surpasses 4,000 surgeries, zero complications; targeting CE mark late 2025, FDA H1 2026

## Summary
- SSi Mantra system used in >4,000 surgeries across >100 types with no complications, injuries, or mortalities.
- Milestone includes ~215 cardiac procedures, of which 6 were telesurgery across India using SSi Mantra 3.
- System cleared for market in 7 countries: India, Nepal, Ecuador, Guatemala, Philippines, Indonesia, Ukraine.
- Company expects CE Mark decision as soon as late 2025 and FDA decision as soon as first half 2026.

## SEC filing metadata
- accession: 0001213900-25-047561
- form_type: 8-K
- ticker: SSII
- cik: 0001676163
- company_name: SS Innovations International, Inc.
- filed_at: 2025-05-27T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676163/000121390025047561/0001213900-25-047561-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676163/000121390025047561/ea0243445-8k_ssinnova.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-047561
- JSON: https://secwatch.observer/filing/0001213900-25-047561.json
- Plain text: https://secwatch.observer/filing/0001213900-25-047561.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.